Clinical Trial Update: The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

View source ↗

Summary

This clinical trial update describes the Expand Study, which aims to expand access to pharmacist-administered long-acting cabotegravir plus rilpivirine for peop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: MetroHealth Medical Center | Conditions: HIV I Infection | Status: NOT_YET_RECRUITING